The Department of Health and Social Care (DHSC) has today (31/03/2026) confirmed the following list of price concessions for March 2026: Please note: Community Pharmacy England has submitted price concession applications for a number of other medicines affected by pricing issues this month. We will issue further updates as soon as we hear back from the [...]
The post March 2026 Price Concessions 4th Update appeared first on Community Pharmacy England.
Department of Health and Social Care (DHSC) has issued a medicine supply notification for Chlordiazepoxide 5mg and 10mg capsules. MSN/2026/021 Tier 2 – Medium impact Date of issue: 30 March 2026 Chlordiazepoxide 5mg and 10mg capsules (Viatris) are out of stock until mid-July 2026. Chlordiazepoxide 10mg capsules (Kent Pharma) have been discontinued. Chlordiazepoxide 5mg capsules [...]
The post Medicine Supply Notification: Chlordiazepoxide 5mg and 10mg capsules appeared first on Community Pharmacy England.
Department of Health and Social Care (DHSC) has issued a medicine supply notification for Cefixime (Suprax®) 200mg tablets. MSN/2026/020 Tier 2 – medium impact Date of issue: 30 March 2026 Cefixime (Suprax®) 200mg tablets are in limited supply until mid-October 2026. Alternative broad-spectrum antibiotics remain available. Unlicensed supplies may be sourced, lead times vary. Unlicensed [...]
The post Medicine Supply Notification: Cefixime (Suprax® ) 200mg tablets appeared first on Community Pharmacy England.
The Department of Health and Social Care (DHSC) has today (27/03/2026) confirmed the following list of price concessions for March 2026: Please note: Community Pharmacy England has submitted price concession applications for a number of other medicines affected by pricing issues this month. We will issue further updates as soon as we hear back from the [...]
The post March 2026 Price Concessions 3rd Update appeared first on Community Pharmacy England.
MHRA Class 4 Medicines Defect Notification: Vesomni 6 mg/0.4 mg modified release tablets (Quadrant Pharmaceuticals Limited) Drug alert number: EL(26)A/16 Date issued: 26 March 2026 Quadrant Pharmaceuticals Limited have informed the MHRA that their parallel imported packs of Vesomni 6 mg/0.4 mg modified release tablets have been printed with the incorrect barcode/GTIN on the carton. DMRC [...]
The post MHRA Class 4 Medicines Defect Notification: Vesomni 6 mg/0.4 mg modified release tablets (Quadrant Pharmaceuticals Limited) appeared first on Community Pharmacy England.
Recent Comments